posted on Jul 27 by MedPage Today OB/Gyn in the Uncategorized category
(MedPage Today) -- The future of bevacizumab (Avastin) as a breast cancer therapy took another turn when the National Comprehensive Cancer Network, a major organization of cancer specialists, voted to continue its support for the indication.